When reading ASX share market news and analysis, we can spend a lot of time on the stocks we already own and the ones we wish we had bought before a big rise, etc.
We've all sat there and thought, "If only I'd just invested X amount into this five years ago!"
For example, it feels like I've read more than 50 articles this year as the CBA share price has hit record high after record high.
Was I ever going to buy when it felt like it was overvalued? Probably not.
Did I read them all anyway – of course!
While it's always valuable to be up to date on share market winners, it can also be worthwhile to watch stocks trading close to all-time lows.
While they might not look attractive, these often provide value and opportunity for long-term investors.
Here are three that are close to 52-week lows worth keeping an eye on.
Image source: Getty Images
Reece Ltd (ASX: REH)
This supplier of plumbing, bathroom, heating ventilation, and air-conditioning products has fallen more than 60% in the last 12 months.
The company has dealt with a soft housing market, cost inflation, and increased competitive threats.
Most recently, it fell 22.6% within two days of its FY25 report.
The bathroom products retailer reported FY25 revenue of $8.98 billion, down 1% from the previous year, and NPAT of $317 million.
However, Ord Minnett has a buy rating and $14.50 price target on its shares. This indicates more than 36% upside.
While the broker does say Reece's near-term outlook remains challenging, it suggests the share price is at a cyclical low.
Morgans has a less optimistic view on this ASX share.
Morgans downgraded Reece shares from a hold to a trim rating with a reduced price target of $11.10.
This still indicates an upside of 4.52%.
Australian Clinical Labs Ltd (ASX: ACL)
This healthcare company operates pathology labs and services in Australia.
Its share price has fallen 20% in the last 12 months.
However, the company did post pleasing FY25 results last month.
It posted a 6.4% increase in total revenue to $741.3 million and a 7.7% lift in underlying net profit after tax to $34 million.
However, Bell Potter's price target indicates an opportunity for this struggling ASX stock.
The broker has an overweight recommendation and $3.50 price target.
This indicates an upside of 37%.
Sonic Healthcare Ltd (ASX: SHL)
Sonic Healthcare is another battered ASX healthcare stock.
It is one of the world's largest medical diagnostics companies, with operations spanning Australia, Europe, and North America.
It has tumbled more than 20% since late August earnings results and is down roughly 15% over the last year.
This was despite a reported revenue of $9,645 million, up 8% year over year, and an NPAT of $514 million, up 7% for FY25.
The price target from Bell Potter also indicates this could be undervalued.
Sonic Healthcare shares closed yesterday at $22.70 each, which is 23% below the broker's price target of $27.96.
